Why vitamin D clinical trials should be based on 25-hydroxyvitamin D concentrations
| dc.contributor.author | Grant, William B. | |
| dc.contributor.author | Boucher, Barbara | |
| dc.contributor.author | Bhattoa, Harjit Pal | |
| dc.contributor.author | Lahore, Henry | |
| dc.date.accessioned | 2018-05-18T09:04:53Z | |
| dc.date.available | 2018-05-18T09:04:53Z | |
| dc.date.issued | 2018 | |
| dc.date.oa | 2018-06-05 | |
| dc.date.pasync | 2020-10-02T00:30:28Z | |
| dc.date.updated | 2020-10-02T00:30:28Z | |
| dc.description.corrector | KA | |
| dc.identifier.citation | Journal Of Steroid Biochemistry And Molecular Biology. -177 (2018), p. 266-269. -J. Steroid Biochem. Mol. Biol. - 0960-0760 | |
| dc.identifier.doi | http://dx.doi.org/10.1016/j.jsbmb.2017.08.009 | |
| dc.identifier.issn | 0960-0760 | |
| dc.identifier.opac | http://webpac.lib.unideb.hu:8082/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM073722 | |
| dc.identifier.uri | http://hdl.handle.net/2437/252462 | |
| dc.identifier.url | http://linkinghub.elsevier.com/retrieve/pii/S0960076017302236 | |
| dc.language | eng | |
| dc.rights.access | open access pre-print és post-print | |
| dc.rights.embargo | 12 | |
| dc.rights.owner | Elsevier | |
| dc.subject.mab | Orvostudományok | |
| dc.subject.mab | Klinikai orvostudományok | |
| dc.title | Why vitamin D clinical trials should be based on 25-hydroxyvitamin D concentrations | |
| dc.type | folyóiratcikk | |
| dc.type | idegen nyelvű folyóiratközlemény külföldi lapban |